In countries such as the United States where rubella virus infections are rare, congenital rubella syndrome (CRS) may not be recognized in a timely manner. However, the syndrome still appears in this country, often in infants of mothers emigrating from countries with absent or suboptimal national vaccination programs. We describe a case of CRS in a term baby born to a recent US immigrant who developed a primary varicella infection in late pregnancy and demonstrated IgG titers to rubella at delivery. At presentation, the neonate had both classical findings as well as less reported vascular and neurological abnormalities seen in infants with CRS.
INTRODUCTION
The childhood rubella epidemic in the United States during the 1960s brought the sequelae of congenital rubella syndrome (CRS) to the attention of practitioners, including the classic triad of sensorineuronal hearing loss, congenital cataracts and cardiac defects. 1 With the implementation of a national mandatory vaccination program in the United States in 1969, the incidence of rubella infections in all age groups decreased significantly over the next 30 years. 2 By 2004, only nine cases of rubella were documented in the United States, 2 and only isolated cases of CRS have been observed here subsequently. CRS can be difficult to diagnose given the unfamiliarity of current pediatric and family medicine practitioners with the disease and its overlapping clinical presentation (microcephaly, rash, systemic organ damage) with other congenital viral infections (such as cytomegalovirus and herpes simplex virus).
Here, we report in detail a case of CRS in a baby that presented with both classic and less recognized physical and radiographic features of the disease. This patient is one of six neonates with CRS in the United States reported recently by the CDC over the past 8 years. 3 Confirmation of the diagnosis in this neonate was confounded by a third-trimester maternal varicella zoster virus infection and documented perinatal maternal antibodies against rubella. However, further investigation of the maternal medical history, coupled with laboratory and clinical evidence in the neonate, led us to the diagnosis of CRS.
CASES
A male infant born at 37 1/7 weeks' gestational age (based on his mother's last menstrual period) was transferred to our Neonatal Intensive Care Unit for evaluation of cardiac defects and multiple congenital anomalies. He was born to a 27-year-old primagravida woman from the United Republic of Tanzania. She initiated prenatal care in her native country at approximately 20 weeks' gestation, where a fetal ultrasound (US) and serologies reportedly were normal.
Shortly after arriving in the United States (about 5 weeks before delivery), the mother developed a febrile illness with associated malaise, upper respiratory symptoms and a widespread pruritic, vesicular rash. She was diagnosed at an outside emergency department with a primary varicella zoster virus infection based on her clinical findings. Her symptoms improved, with the vesicles crusting over in less than a week.
At 35 4/7 weeks' gestation, she was admitted to an outside hospital with abdominal pain and decreased fetal movement. Fetal US demonstrated an estimated fetal weight in the 3rd percentile, a single umbilical artery (SUA), cardiomegaly, macrocephaly and oligohydramnios. Amniocentesis was performed the next day; analysis of the fluid by PCR (for cytomegalovirus, varicella zoster virus and Toxoplasma gondii), and fluorescent in-situ hybridization (for trisomies) was unremarkable. Maternal serologies were negative for Hepatitis B surface antigen and HIV antibody. Her rapid plasma reagin was positive (titer 1:1) with a negative treponemal confirmatory test, and her rubella IgG titer was greater than 400 IU ml À 1 (negative less than 5 IU ml
). Chlamydia trachomatis testing by nucleic acid probe was negative; screening for Group B Streptococcus and Neisseria gonorrhoeae was not done.
Oligohydramnios prompted delivery of the infant 11 days later via Cesarean section; he had Apgars of 5 and 8 at 1 and 5 min of age. His birth weight (1910 g) and length (41 cm) were less than the 2nd percentile for gestational age, but his head circumference (32.5 cm) was between 5th and 10th percentile for gestational age. , normal: 7.6 to 10.4 mg dl À 1 ). Cranial US on the newborn day demonstrated hydrocephalus, widening of the lateral ventricles, bilateral echogenic cysts within the caudothalamic notches extending into the ventricular system, and a ruptured septum pellucidum. He had an unremarkable cardiac exam at birth, but developed a harsh, holosystolic III/VI murmur by the next day. Echocardiography revealed a hypoplastic transverse aortic arch, a large patent ductus arteriosus and a dilated right ventricle with moderately depressed right ventricular function. He was intubated and transferred to our institution for further evaluation and medical management.
In our Neonatal Intensive Care Unit, the baby was placed in contact isolation. Significant physical findings included a twovessel umbilical cord, a wide anterior fontanelle, posteriorly rotated ears, abdominal petechiae and multiple brown-purple macules scattered over his groin and back. Ophthalmology exam of the infant revealed bilateral nuclear cataracts (Figure 1 ), microophthalmia, 'steamy' keratitis and pupillary miosis. Laboratory analyses for infections with bacteria, multiple viruses (including cytomegalovirus, herpes simplex virus, varicella zoster virus and human immunodeficiency virus (HIV)) and Toxoplasma were performed and were negative. However, rubella IgM titers from his serum were positive at 2 and 7 days of age at 5.14 and 4.39, respectively (normal less than 1.1). Serum rubella IgG was also detected at 7 days of age (titer not reported). His nasophargyneal viral culture was positive for rubella virus, genotype 1G (a genotype known to circulate in central Africa 4 ), as documented by failure of cellular cytopathic effect in African green monkey kidney cells after echovirus 11 superinfection (Supplementary Figure 1) .
Given the infant's physical findings and confirmatory laboratory evidence, he was diagnosed with CRS. Retrospective questioning of the mother revealed that she developed a diffuse, erythematous rash (not associated with fever) at the time of her first missed menstrual period that resolved within a few days without intervention. She provided us with her childhood immunization records from Tanzania, which showed she was immunized against measles at 18 months of age but never received rubella or varicella vaccinations.
A follow-up cranial US at 4 days of age demonstrated subependymal cysts and bilateral basal ganglia mineralizing vasculopathy ( Figure 2 ). Cranial magnetic resonance imaging performed at 9 days of age confirmed the prior US findings and also showed mild hypomyelination of the hemispheric white matter as well as a simplified gyration pattern. The lateral ventriculomegaly was stable compared with his original cranial US, while the third and fourth ventricle were of normal size, suggesting an obstructive etiology (Figure 2 ). Abdominal US was unremarkable. Long bone survey showed subtle signs of metaphyseal fraying and longitudinal radiolucent and radiodense stripes ('celery stalking', Supplementary Figure 2) . Karyotype, singlenucleotide polymorphism array and fluorescent in-situ hybridization probe for the 22q11.2 deletion were all unremarkable.
Repeat echocardiography at 10 days of age revealed a persistent patent ductus arteriosus with bidirectional flow, right ventricular pressure almost equal to systemic pressure and moderate coarctation of the aorta. At 14 days of age, the baby underwent a patent ductus arteriosus ligation and left subclavian flap aortoplasty. He recovered well post-operatively, and advanced to complete nipple feeds by 21 days of age.
At 35 days of age, he underwent bilateral lensectomy and anterior vitrectomy, and was fitted later with custom rigid contact lenses. Follow-up cranial US at 46 days of age showed stable, mild ventriculomegaly. Ophthalmologic exam at 3 months of age revealed visual function adequate to make eye contact without evidence of nystagmus or strabismus. Retinal mottling was noted at that time, and a repeat exam under anesthesia 1 month later confirmed salt-and-pepper retinopathy. Auditory brainstem response audiometry in sleep at 5 months of age demonstrated bilateral, profound sensorineural hearing loss from 500 to 4000 Hz, and he was fitted with binaural, behind-the-ear hearing aids.
At his 6-month well-child appointment, his weight (5520 g) and length (61.5 cm) remained less than the 2nd percentile for age, and his head circumference (41.5 cm) was between 5th and 10th percentile for age. He was able to visually track an object in all directions, bring both hands to midline, and use a raking grasp. In addition, he was babbling, alert and smiling. He was unable to support his head while positioned prone or roll over, but had achieved these milestones by a 7-month pediatric neurology followup appointment. His developmental quotient was 71 (based on CAT/CLAMS) at this latter visit, with better performance on the language stream relative to the visual/motor stream.
At his 12-month well-child appointment, his growth parameters were stable, with weight (6980 g) and length (70 cm) remaining below the 2nd percentile for age, and head circumference (44.5 cm) at the 10th percentile for age. He could pull to a seated position but lacked the truncal tone to sit independently. He vocalized frequently though he did not have any words. At his audiology visit during the same month, his receptive and expressive language skills (based on the standardized Preschool Language Scale) were equivalent to that of a 5-month old. He was deemed an appropriate candidate for bilateral cochlear implants; he received his right-sided implant at 14 months of age. Secondary intraocular lens implantation is planned for around 2 years of age if the eye is of a sufficient size.
DISCUSSION
In the current era, CRS remains a diagnostic challenge. The association of ophthalmologic and cardiac anomalies with rubella infection was posited first by Gregg in 1941. 5 Ocular findings are seen in 70 to 80% of CRS cases, with pigmentary retinopathy seen in 60% and congenital cataracts found in 20 to 30% in one cohort. 6, 7 In addition, in developing countries, CRS represents the most common cause of congenital cataracts. Other clinical features, including congenital hearing loss, purpura and thrombocytopenia, have been described previously, 8 and were present in our neonate. However, our patient also demonstrated unique physical findings, including SUA, neuroimaging abnormalities and relative 'head-sparing' growth restriction less commonly seen in neonates with CRS. On our initial evaluation of the baby, we considered chromosomal abnormalities (such as DiGeorge syndrome) in the differential diagnosis of his case given the cardiac anomaly and hypocalcemia at birth. Based on maternal history, congenital varicella syndrome was also entertained; however, the onset of her illness at approximately 32 weeks' gestation (after the critical period of organogenesis) made this condition less likely. Finally, documentation of positive maternal rubella IgG titers during third trimester screening in the United States further confounded the clinical picture. We recognized, although, that the titers could represent a maternal antibody response to vaccination (the more common scenario in pregnant women in the United States), or seroconversion after a first trimester rubella infection, the latter of which was confirmed in this patient's mother. Our case emphasizes the importance of maintaining a broad differential diagnosis in the setting of atypical features of a rarely encountered syndrome, and carefully interpreting antenatal laboratories and history in the clinical context of the patient.
The rubella virus is known to have a tropism for the central nervous system, and children with CRS are at risk for intellectual disability, motor impairments and behavioral disorders. 9 Our patient had neurodevelopmental findings associated with CRS on physical exam (motor delay) and audiologic testing (sensorineural hearing loss) as an infant. In addition, although detailed analyses of neuroimaging in this disease are limited, 10 his neonatal imaging demonstrated previously described central nervous system findings of CRS, including basal ganglia mineralizing vasculopathy/calcification, delayed myelination and the presence of subependymal cysts. 11, 12, 13 However, microcephaly was conspicuously absent in our patient. We hypothesize this presentation may be due to concomitant obstructive hydrocephalus, as suggested by his magnetic resonance image that showed enlargement of the lateral ventricles relative to the third and fourth ventricles. An obstructive etiology is further supported by the presence of the large subependymal cysts adjacent to the foramen of Monro. Ventriculomegaly has been reported in CRS, but typically is thought to represent ex vacuo atrophy. 11 It is plausible, then, that in our case, a mild degree of obstructive hydrocephalus was present, thus masking microcephaly that would be typically expected with an intrauterine rubella infection. In addition, post-infectious adhesions within the region of the Sylvian aqueduct cannot be excluded as possible additional etiology of the ventriculomegaly.
A documented fetal SUA has been associated with renal and cardiac anomalies as well as intrauterine growth restriction.
14 In addition, SUA represents a recognized but less commonly reported complication of CRS, and theoretically occurs due to inhibition of growth of the developing umbilical blood vessels in utero. 15, 16 This physical finding highlights the pathogenesis of CRS: cellular disruption and cytopathic vascular damage by viral invasion and cellular apoptosis and growth inhibition during the hyperplastic phase of cell development in the first trimester of pregnancy. 17 The resultant disruption of intrauterine growth and organogenesis results in low birth weight and abnormal end-organ development in affected patients, including in our patient.
Endemic transmission of rubella and CRS were declared eliminated in this country when the last case of CRS in a baby born to a native U.S. mother was documented between 2001 and 2004. 1 However, sporadic cases still occur here in children of foreign born mothers. 3, 18 In contrast, in Africa and in other parts of the developing world, rubella and CRS remain problematic. The incidence of CRS in the World Health Organization (WHO) Africa region was estimated at 22 500 cases annually in the mid-1990s. 19 In 2009, 167 WHO member states reported a total of 121 344 cases of rubella and 165 cases of CRS; 17 388 rubella cases and 47 CRS cases were reported from the WHO Africa region. 20 In Tanzania, the country of origin of our patient's mother, 623 cases of rubella infection were reported from 2002 to 2009, with 6% occurring in women of child-bearing age. 19 The persistence of rubella and CRS in Africa is due likely to the lack of rubella immunization in national vaccination programs. One fear in introducing the rubella vaccine in low-immunity countries, as raised in a recent Centers for Disease Control/WHO report, is a shift in rubella susceptibility
